DrugPatentWatch Database Preview
Novitium Pharma Company Profile
» See Plans and Pricing
What is the competitive landscape for NOVITIUM PHARMA, and what generic and branded alternatives to NOVITIUM PHARMA drugs are available?
NOVITIUM PHARMA has seventeen approved drugs.
There is one tentative approval on NOVITIUM PHARMA drugs.
Summary for Novitium Pharma
| US Patents: | 0 |
| Tradenames: | 17 |
| Ingredients: | 16 |
| NDAs: | 17 |
| Patent Litigation for Novitium Pharma: | See patent lawsuits for Novitium Pharma |
Drugs and US Patents for Novitium Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novitium Pharma | PREDNISONE | prednisone | TABLET;ORAL | 211575-005 | Nov 15, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novitium Pharma | DAPSONE | dapsone | TABLET;ORAL | 206505-001 | Dec 1, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Novitium Pharma | PYRIDOSTIGMINE BROMIDE | pyridostigmine bromide | SYRUP;ORAL | 211694-001 | Mar 8, 2019 | AA | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
